Audiometry - Design and analysis of signal processing procedures for objective audiometry in newborns.
From 01-01-2004 to 31-12-2007
Description
Since 1998, the hearing of 96.5% of all newborns in Flanders is tested by Kind & Gezin. Children with hearing problems have to be supported by hearing aids as soon as possible. For the fitting of a hearing aid and for general diagnostic purposes, it is necessary to quantify the hearing thresholds of these children in an objective way. The ultimate goal of the field of objective audiometry, using an electrofysiologic measuring technique, is the generation of an accurate audiogram in a frequency specific way. A couple of years ago, research has been started on several techniques using 'Auditory Steady State Responses' (ASSR) to execute objective and frequency specific threshold measurements. Unfortunately, the present setup, based on this technique of ASSR, is not yet clinically applicable due to the measurement time which is too long. Because of this, anaesthesia is often needed which can be harmful for the young patient. The purpose of the study is to investigate the possibilities to shorten the measurement time using different techniques out of the domain of signal processing.Team
- Marc Moonen, Co-promoter
- Bram Van Dun, Team member
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.